Kulkarni Sandeep Chidambar's Form 4 filing
Tourmaline Bio, Inc. (TRML) · filed Oct 26, 2023
- Accession no.
- 0001209191-23-053691
- Filed
- Oct 26, 2023
- Trade date
- Oct 24-26, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $110.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kulkarni Sandeep ChidambarCIK 0001945691 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2023 | Common Stock | PPurchaseAcquired | +4,650 | $10.68 | +$49,662 | 720,735 | Direct | |
| Oct 26, 2023 | Common Stock | PPurchaseAcquired | +5,000 | $12.25 | +$61,250 | 725,735 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.